A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELLVACCINE TRIAL

Condition:   COVID-19 Interventions:   Biological: hAd5-S-Fusion+N-ETSD;   Biological: Placebo (0.9% (w/v) saline) Sponsor:   ImmunityBio, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials